| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/29/2011 | US20110237524 Polymer conjugates of aod-like peptides |
| 09/29/2011 | US20110237523 CONTRACEPTIVE PEPTIDES DERIVED FROM THE VENOM OF THE SPIDER Latrodectus mirabilis, NUCLEOTIDE SEQUENCES TO TRANSFORM A MICROORGANISM TO PRODUCE SAID PEPTIDES; METHODS TO OBTAIN THE PEPTIDES; PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USE THEREOF |
| 09/29/2011 | US20110237520 Anticancer Compounds |
| 09/29/2011 | US20110237518 Method for treating or preventing bladder cancer using the depdc1 polypeptide |
| 09/29/2011 | US20110237516 Plant-derived elastin binding protein ligands and methods of using the same |
| 09/29/2011 | US20110237515 Peptide derived from neurotesin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 09/29/2011 | US20110237507 Methods of protecting against apoptosis using lipopeptides |
| 09/29/2011 | US20110237499 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses |
| 09/29/2011 | US20110237494 Use of peptidic vasopression receptor agonists |
| 09/29/2011 | US20110236931 Chemical and biochemical adducts as biomarkers for organophosphate exposure |
| 09/29/2011 | US20110236484 Genus-Wide Chlamydial Peptide Vaccine Antigens |
| 09/29/2011 | US20110236429 Small Cationic Antimicrobial Peptides |
| 09/29/2011 | US20110236410 Klebsiella antigens |
| 09/29/2011 | US20110236406 Immunogenic compositions comprising hmgb1 polypeptides |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236316 Peptide targeting imaging agents and methods of use thereof |
| 09/29/2011 | US20110236313 Human salty taste receptor and methods of modulating salty taste perception |
| 09/29/2011 | US20110236311 Radiolabelling methods |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | CA2830687A1 Salt-resistant emulsions |
| 09/29/2011 | CA2800248A1 Compounds to be used in the treatment of diseases based on the expression of toxic transcripts |
| 09/28/2011 | EP2368902A2 Insulin and IGF-1 receptor agonists and antagonists |
| 09/28/2011 | EP2368901A1 Peptidomimetic protease inhibitors |
| 09/28/2011 | EP2368900A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 09/28/2011 | EP2368899A1 Avian influenza vaccine |
| 09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 09/28/2011 | EP2368878A1 Peptidomimetic protease inhibitors |
| 09/28/2011 | EP2368877A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 09/28/2011 | EP2368561A1 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 09/28/2011 | EP2367842A1 Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same |
| 09/28/2011 | EP2367840A1 Single-chain antiparallel coiled coil proteins |
| 09/28/2011 | EP2367561A1 Compositions and methods for treatment of celiac disease |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | CN1897951B Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 09/28/2011 | CN102203291A Tbc1d7 as tumor marker and therapeutic target for cancer |
| 09/28/2011 | CN102203119A Human catechol-o-methyltransferase (comt) assay |
| 09/28/2011 | CN102203118A Peptide antagonist of interleukin-15 activity |
| 09/28/2011 | CN102203117A APJ receptor compounds |
| 09/28/2011 | CN102203116A Amphiphilic peptide promoting the formation of a target mirna, and method for controlling the formation of the target mirna using same |
| 09/28/2011 | CN102202679A Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 09/28/2011 | CN102199195A Half-path charge matching amphiphilic self assembling short peptide, and its application as nanometer hemostatic material and hydrophobic drug carrier |
| 09/28/2011 | CN102199188A Liquid-phase synthesis method for polypeptide |
| 09/28/2011 | CN101463072B Preparation of cholecystokinin octapeptide |
| 09/28/2011 | CN101307094B Novel nuclear factor -kappa B p65 subunit antagonizing polypeptide |
| 09/28/2011 | CN101163799B 肽稳定剂化合物及筛选方法 Peptide stabilizer compounds and screening methods |
| 09/27/2011 | US8026341 Transfection complexes |
| 09/27/2011 | US8026210 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
| 09/27/2011 | US8026208 Peptide tyrosinase inhibitors and uses thereof |
| 09/27/2011 | US8026058 PCR hot start by magnesium sequestration |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | US8025872 Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same |
| 09/27/2011 | CA2537421C Peptides and compounds that bind to thrombopoietin receptor |
| 09/27/2011 | CA2468849C Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 09/22/2011 | WO2011116245A2 Methods of treating inflammation |
| 09/22/2011 | WO2011115819A2 Small molecule inhibitors of muc1 and methods of identifying the same |
| 09/22/2011 | WO2011115812A2 Affinity peptides toward bmp-2 |
| 09/22/2011 | WO2011115688A2 Integrin interaction inhibitors for the treatment of cancer |
| 09/22/2011 | WO2011115462A2 Seed-conjugated solid support resin, and method for removing β2-microglobulin by using same |
| 09/22/2011 | WO2011115420A2 Adhesive extracellular matrix mimetic |
| 09/22/2011 | WO2011115225A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 09/22/2011 | WO2011114071A2 Synthetic cyclopeptide, preparation process and uses |
| 09/22/2011 | WO2011113882A1 Diagnosis and treatment of cancer based on avl9 |
| 09/22/2011 | WO2011113872A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers |
| 09/22/2011 | WO2011113604A1 Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein |
| 09/22/2011 | WO2011094617A3 Peptide domains that bind small molecules of industrial significance |
| 09/22/2011 | WO2011055980A3 Composite of a protein comprising zinc oxide-bonding peptides and zinc oxide nanoparticles, and use thereof |
| 09/22/2011 | US20110231960 Bacterial toxin vaccine |
| 09/22/2011 | US20110230640 Methods for characterizing glycoproteins and generating antibodies for same |
| 09/22/2011 | US20110230639 Immunomodulatory peptides |
| 09/22/2011 | US20110230638 Methods for detection of cyclosporin a |
| 09/22/2011 | US20110230427 Materials and methods for stabilizing nanoparticles in salt solutions |
| 09/22/2011 | US20110230426 Template-fixed peptidomimetics |
| 09/22/2011 | US20110230416 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 09/22/2011 | US20110230406 Affinity peptides toward bmp-2 |
| 09/22/2011 | US20110230405 Peptides and Supported Peptides for Treating Skin Diseases |
| 09/22/2011 | US20110230397 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229504 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/22/2011 | US20110229481 Cancer-associated antigen analogue peptides and uses thereof |
| 09/22/2011 | US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity |
| 09/22/2011 | US20110229453 Blood coagulation factor inhibitors |
| 09/22/2011 | US20110229414 Contrast Agents For Detecting Protease Activity By Means Of Hyperpolarization And For Stratifying Patients |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110226621 Target recognition molecule and a method for immobilizing the same |
| 09/22/2011 | US20110226620 Highly Homogeneous Molecular Markers for Electrophoresis |
| 09/22/2011 | CA2793838A1 Integrin interaction inhibitors for the treatment of cancer |
| 09/22/2011 | CA2793389A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers |
| 09/22/2011 | CA2793181A1 Nanotubes and compositions thereof |
| 09/22/2011 | CA2792611A1 Affinity peptides toward bmp-2 |
| 09/22/2011 | CA2789857A1 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/21/2011 | EP2367008A2 Modulating the interaction betwenn HGF beta chain and C-Met |
| 09/21/2011 | EP2366786A2 Cytokine receptor modulators and uses thereof |
| 09/21/2011 | EP2366027A2 Rapid fret-based diagnosis of bacterial pathogen |
| 09/21/2011 | EP2365820A2 Endothelium mimicking nanomatrix |
| 09/21/2011 | EP2076529B1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 09/21/2011 | EP1549333B1 Compstatin analogues with improved activity |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN102197046A Peptidomimetic marcrocycles |